Filed: 8/14/2025ACC: 0001636587-25-000043
📋 What this filing means
ACORN CAPITAL ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 21 equity positions with a total reported market value of $152.89M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
21
Positions
$152.89M
Total AUM (reported)
34.12M
Total Shares
Allocation by class
COM$134.15M87.7%
CLASS A COM$6.79M4.4%
COM NEW$6.16M4.0%
COM STK$5.31M3.5%
COMMON STOCK$482.2K0.3%
Portfolio Concentration
Top 3$62.10M40.6%
4–10$65.24M42.7%
11–25$25.56M16.7%
Top 3 weight
40.6%
Top 10 weight
83.3%
Voting Authority Distribution
Total shares with voting rights: 34.12M
Sole
Full voting authority
34.12M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole21
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings21
Rows:
CG ONCOLOGY INC
SOLEShares1.13M
TypeSH
Market value$29.42M
19.24%
Sole
1.13M
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares1.26M
TypeSH
Market value$17.26M
11.29%
Sole
1.26M
Shared
0.00
None
0.00
Y-MABS THERAPEUTICS INC
SOLEShares3.42M
TypeSH
Market value$15.42M
10.09%
Sole
3.42M
Shared
0.00
None
0.00
PUMA BIOTECHNOLOGY INC
SOLEShares4.13M
TypeSH
Market value$14.17M
9.27%
Sole
4.13M
Shared
0.00
None
0.00
CANDEL THERAPEUTICS INC
SOLEShares2.58M
TypeSH
Market value$13.06M
8.54%
Sole
2.58M
Shared
0.00
None
0.00
TREVI THERAPEUTICS INC
SOLEShares2.14M
TypeSH
Market value$11.73M
7.67%
Sole
2.14M
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares1.97M
TypeSH
Market value$7.35M
4.81%
Sole
1.97M
Shared
0.00
None
0.00
ONKURE THERAPEUTICS INC
SOLEShares2.84M
TypeSH
Market value$6.79M
4.44%
Sole
2.84M
Shared
0.00
None
0.00
CYBIN INC
SOLEShares734.39K
TypeSH
Market value$6.16M
4.03%
Sole
734.39K
Shared
0.00
None
0.00
BICARA THERAPEUTICS
SOLEShares643.38K
TypeSH
Market value$5.98M
3.91%
Sole
643.38K
Shared
0.00
None
0.00
PROTARA THERAPEUTICS INC
SOLEShares1.75M
TypeSH
Market value$5.31M
3.47%
Sole
1.75M
Shared
0.00
None
0.00
CARDIF ONCOLOGY INC
SOLEShares1.41M
TypeSH
Market value$4.44M
2.90%
Sole
1.41M
Shared
0.00
None
0.00
AURA BIOSCIENCES INC
SOLEShares595.74K
TypeSH
Market value$3.73M
2.44%
Sole
595.74K
Shared
0.00
None
0.00
VERASTEM INC
SOLEShares779.50K
TypeSH
Market value$3.23M
2.12%
Sole
779.50K
Shared
0.00
None
0.00
WHITEHAWK THERAPEUTICS INC
SOLEShares1.14M
TypeSH
Market value$2.13M
1.39%
Sole
1.14M
Shared
0.00
None
0.00
BIOATLA INC
SOLEShares4.84M
TypeSH
Market value$1.91M
1.25%
Sole
4.84M
Shared
0.00
None
0.00
MURAL ONCOLOGY PLC
SOLEShares653.78K
TypeSH
Market value$1.61M
1.06%
Sole
653.78K
Shared
0.00
None
0.00
VYNE THERAPEUTICS INC
SOLEShares736.57K
TypeSH
Market value$1.22M
0.79%
Sole
736.57K
Shared
0.00
None
0.00
Q32 BIO INC.
SOLEShares803.42K
TypeSH
Market value$1.20M
0.78%
Sole
803.42K
Shared
0.00
None
0.00
ACRIVON THERAPEUTICS INC
SOLEShares405.24K
TypeSH
Market value$482.2K
0.32%
Sole
405.24K
Shared
0.00
None
0.00
X4 PHARMACEUTICALS INC
SOLEShares153.73K
TypeSH
Market value$292.1K
0.19%
Sole
153.73K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CG ONCOLOGY INCSOLE | COM | 1.13M | SH | $29.42M 19.24% | 1.13M | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 1.26M | SH | $17.26M 11.29% | 1.26M | 0.00 | 0.00 |
Y-MABS THERAPEUTICS INCSOLE | COM | 3.42M | SH | $15.42M 10.09% | 3.42M | 0.00 | 0.00 |
PUMA BIOTECHNOLOGY INCSOLE | COM | 4.13M | SH | $14.17M 9.27% | 4.13M | 0.00 | 0.00 |
CANDEL THERAPEUTICS INCSOLE | COM | 2.58M | SH | $13.06M 8.54% | 2.58M | 0.00 | 0.00 |
TREVI THERAPEUTICS INCSOLE | COM | 2.14M | SH | $11.73M 7.67% | 2.14M | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 1.97M | SH | $7.35M 4.81% | 1.97M | 0.00 | 0.00 |
ONKURE THERAPEUTICS INCSOLE | CLASS A COM | 2.84M | SH | $6.79M 4.44% | 2.84M | 0.00 | 0.00 |
CYBIN INCSOLE | COM NEW | 734.39K | SH | $6.16M 4.03% | 734.39K | 0.00 | 0.00 |
BICARA THERAPEUTICSSOLE | COM | 643.38K | SH | $5.98M 3.91% | 643.38K | 0.00 | 0.00 |
PROTARA THERAPEUTICS INCSOLE | COM STK | 1.75M | SH | $5.31M 3.47% | 1.75M | 0.00 | 0.00 |
CARDIF ONCOLOGY INCSOLE | COM | 1.41M | SH | $4.44M 2.90% | 1.41M | 0.00 | 0.00 |
AURA BIOSCIENCES INCSOLE | COM | 595.74K | SH | $3.73M 2.44% | 595.74K | 0.00 | 0.00 |
VERASTEM INCSOLE | COM | 779.50K | SH | $3.23M 2.12% | 779.50K | 0.00 | 0.00 |
WHITEHAWK THERAPEUTICS INCSOLE | COM | 1.14M | SH | $2.13M 1.39% | 1.14M | 0.00 | 0.00 |
BIOATLA INCSOLE | COM | 4.84M | SH | $1.91M 1.25% | 4.84M | 0.00 | 0.00 |
MURAL ONCOLOGY PLCSOLE | COM | 653.78K | SH | $1.61M 1.06% | 653.78K | 0.00 | 0.00 |
VYNE THERAPEUTICS INCSOLE | COM | 736.57K | SH | $1.22M 0.79% | 736.57K | 0.00 | 0.00 |
Q32 BIO INC.SOLE | COM | 803.42K | SH | $1.20M 0.78% | 803.42K | 0.00 | 0.00 |
ACRIVON THERAPEUTICS INCSOLE | COMMON STOCK | 405.24K | SH | $482.2K 0.32% | 405.24K | 0.00 | 0.00 |
X4 PHARMACEUTICALS INCSOLE | COM | 153.73K | SH | $292.1K 0.19% | 153.73K | 0.00 | 0.00 |